JP6385273B6 - 高純度結晶性ジメチルフマラートの調製方法 - Google Patents

高純度結晶性ジメチルフマラートの調製方法 Download PDF

Info

Publication number
JP6385273B6
JP6385273B6 JP2014514905A JP2014514905A JP6385273B6 JP 6385273 B6 JP6385273 B6 JP 6385273B6 JP 2014514905 A JP2014514905 A JP 2014514905A JP 2014514905 A JP2014514905 A JP 2014514905A JP 6385273 B6 JP6385273 B6 JP 6385273B6
Authority
JP
Japan
Prior art keywords
dimethyl fumarate
dimethyl
methanol
reaction
fumarate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2014514905A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014522413A (ja
JP6385273B2 (ja
JP2014522413A5 (enExample
Inventor
ジョン グゾウスキー，
ウィリアム キースマン，
アーウィン イルダム，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biogen MA Inc
Original Assignee
Biogen MA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47296498&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP6385273(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biogen MA Inc filed Critical Biogen MA Inc
Publication of JP2014522413A publication Critical patent/JP2014522413A/ja
Publication of JP2014522413A5 publication Critical patent/JP2014522413A5/ja
Application granted granted Critical
Publication of JP6385273B2 publication Critical patent/JP6385273B2/ja
Publication of JP6385273B6 publication Critical patent/JP6385273B6/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/08—Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/62—Use of additives, e.g. for stabilisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/52—Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/28—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/297—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/593—Dicarboxylic acid esters having only one carbon-to-carbon double bond
    • C07C69/60—Maleic acid esters; Fumaric acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/604—Polycarboxylic acid esters, the acid moiety containing more than two carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
JP2014514905A 2011-06-08 2012-06-08 高純度結晶性ジメチルフマラートの調製方法 Expired - Fee Related JP6385273B6 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161494775P 2011-06-08 2011-06-08
US61/494,775 2011-06-08
PCT/US2012/041715 WO2012170923A1 (en) 2011-06-08 2012-06-08 Process for preparing high purity and crystalline dimethyl fumarate

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2016111809A Division JP2016155868A (ja) 2011-06-08 2016-06-03 高純度結晶性ジメチルフマラートの調製方法
JP2018107557A Division JP2018162266A (ja) 2011-06-08 2018-06-05 高純度結晶性ジメチルフマラートの調製方法

Publications (4)

Publication Number Publication Date
JP2014522413A JP2014522413A (ja) 2014-09-04
JP2014522413A5 JP2014522413A5 (enExample) 2015-07-23
JP6385273B2 JP6385273B2 (ja) 2018-09-05
JP6385273B6 true JP6385273B6 (ja) 2023-12-15

Family

ID=47296498

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2014514905A Expired - Fee Related JP6385273B6 (ja) 2011-06-08 2012-06-08 高純度結晶性ジメチルフマラートの調製方法
JP2016111809A Pending JP2016155868A (ja) 2011-06-08 2016-06-03 高純度結晶性ジメチルフマラートの調製方法
JP2018107557A Pending JP2018162266A (ja) 2011-06-08 2018-06-05 高純度結晶性ジメチルフマラートの調製方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2016111809A Pending JP2016155868A (ja) 2011-06-08 2016-06-03 高純度結晶性ジメチルフマラートの調製方法
JP2018107557A Pending JP2018162266A (ja) 2011-06-08 2018-06-05 高純度結晶性ジメチルフマラートの調製方法

Country Status (32)

Country Link
US (1) US9422226B2 (enExample)
EP (1) EP2718257B1 (enExample)
JP (3) JP6385273B6 (enExample)
KR (2) KR20150080037A (enExample)
CN (1) CN103649041A (enExample)
AU (1) AU2012267524A1 (enExample)
BR (1) BR112013031616A2 (enExample)
CA (1) CA2838271A1 (enExample)
CL (1) CL2013003483A1 (enExample)
CO (1) CO6821956A2 (enExample)
CY (1) CY1119920T1 (enExample)
DK (1) DK2718257T3 (enExample)
EA (1) EA201391638A1 (enExample)
EC (1) ECSP14013123A (enExample)
ES (1) ES2659771T3 (enExample)
HR (1) HRP20180203T1 (enExample)
HU (1) HUE036085T2 (enExample)
IL (1) IL229656A0 (enExample)
LT (1) LT2718257T (enExample)
ME (1) ME02960B (enExample)
MX (1) MX355421B (enExample)
NO (1) NO2820009T3 (enExample)
NZ (1) NZ618178A (enExample)
PE (1) PE20141639A1 (enExample)
PH (1) PH12013502498A1 (enExample)
PL (1) PL2718257T3 (enExample)
PT (1) PT2718257T (enExample)
RS (1) RS56972B1 (enExample)
SG (1) SG195227A1 (enExample)
SI (1) SI2718257T1 (enExample)
SM (1) SMT201800098T1 (enExample)
WO (1) WO2012170923A1 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1663197T3 (da) 2003-09-09 2008-01-07 Fumapharm Ag Anvendelse af fumarsyrederivater til behandling af hjerteinsuffiens og astma
SI1799196T1 (sl) 2004-10-08 2016-10-28 Forward Pharma A/S Farmacevtski sestavki z nadzorovanim sproščanjem, obsegajoči ester fumarne kisline
MX2011001341A (es) 2008-08-19 2011-03-29 Xenoport Inc Prodrogas de metil hidrogeno fumarato, sus composiciones farmaceuticas, y metodos de uso.
PE20141639A1 (es) 2011-06-08 2014-11-08 Biogen Idec Inc Proceso para preparar fumarato de dimetilo de alta pureza y cristalino
US9597292B2 (en) 2012-08-22 2017-03-21 Xenoport, Inc. Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
EP2887934A1 (en) 2012-08-22 2015-07-01 XenoPort, Inc. Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects
AR094277A1 (es) 2012-12-21 2015-07-22 Biogen Idec Inc Derivados de fumarato sustituidos con deuterio
US8669281B1 (en) 2013-03-14 2014-03-11 Alkermes Pharma Ireland Limited Prodrugs of fumarates and their use in treating various diseases
MX386935B (es) 2013-03-14 2025-03-04 Alkermes Pharma Ireland Ltd Profármacos de fumaratos y su uso en el tratamiento de diferentes enfermedades.
US10179118B2 (en) 2013-03-24 2019-01-15 Arbor Pharmaceuticals, Llc Pharmaceutical compositions of dimethyl fumarate
CN104098471A (zh) * 2013-04-03 2014-10-15 南京卡文迪许生物工程技术有限公司 富马酸二甲酯多晶型物及其制备方法和药物组合物
WO2014197860A1 (en) 2013-06-07 2014-12-11 Xenoport, Inc. Method of making monomethyl fumarate
US9421182B2 (en) 2013-06-21 2016-08-23 Xenoport, Inc. Cocrystals of dimethyl fumarate
JP2016534133A (ja) 2013-09-06 2016-11-04 ゼノポート，インコーポレイティド （ｎ，ｎ−ジエチルカルバモイル）メチル メチル（２ｅ）ブト−２−エン−１，４−ジオエートの結晶形態、その合成方法及び使用
IN2013MU03070A (enExample) * 2013-09-25 2015-07-17 Glenmark Pharmaceuticals Ltd
WO2014203231A2 (en) * 2014-01-24 2014-12-24 Shilpa Medicare Limited Process for preparation of dimethyl-(e)-butenedioate
JP6337135B2 (ja) 2014-02-24 2018-06-06 アルカーメス ファーマ アイルランド リミテッド フマル酸エステルのスルホンアミドプロドラッグ及びスルフィンアミドプロドラッグ並びに種々の疾患の治療におけるその使用
US9326947B1 (en) 2014-02-28 2016-05-03 Banner Life Sciences Llc Controlled release fumarate esters
US9636318B2 (en) 2015-08-31 2017-05-02 Banner Life Sciences Llc Fumarate ester dosage forms
US10098863B2 (en) 2014-02-28 2018-10-16 Banner Life Sciences Llc Fumarate esters
CA2939990C (en) 2014-02-28 2018-07-10 Banner Life Sciences Llc Controlled release enteric soft capsules of fumarate esters
ES2777273T3 (es) * 2014-03-17 2020-08-04 Biophore India Pharmaceuticals Pvt Ltd Procedimiento mejorado para la síntesis de dimetil fumarato
US9999672B2 (en) 2014-03-24 2018-06-19 Xenoport, Inc. Pharmaceutical compositions of fumaric acid esters
EP3164378A1 (en) * 2014-07-03 2017-05-10 Synthon B.V. Process for making microcrystalline dimethyl fumarate
CN104151165B (zh) * 2014-08-11 2016-08-24 广东东阳光药业有限公司 制备富马酸二甲酯的方法
CN104761453A (zh) * 2015-04-22 2015-07-08 河南中帅医药科技股份有限公司 一种富马酸二甲酯晶型及其制备方法
WO2016194004A1 (en) * 2015-06-01 2016-12-08 Sun Pharmaceutical Industries Ltd. Pharmaceutical compositions of dimethyl fumarate
EA201890068A1 (ru) 2015-06-17 2018-09-28 Байоджен Ма Инк. Частицы диметилфумарата и фармацевтические композиции на их основе
CN106316841A (zh) * 2015-06-30 2017-01-11 深圳翰宇药业股份有限公司 一种富马酸二甲酯的制备方法
WO2017013672A1 (en) * 2015-07-23 2017-01-26 Natco Pharma Ltd Process for the preparation of pharmaceutical grade dimethyl fumarate
US10011663B2 (en) 2016-02-04 2018-07-03 Eastman Chemical Company Vulcanizing composition containing cyclododecasulfur and improved cyclododecasulfur compound
RU2616605C1 (ru) * 2016-04-07 2017-04-18 Олег Ростиславович Михайлов Кристаллическая бета - модификация (Е)-диметилбутендиоата, способ её получения и фармацевтическая композиция на её основе
CN107285320A (zh) * 2017-08-02 2017-10-24 内蒙古新福地科技有限公司 一种氟硅酸钠的结晶方法及装置
SI3694863T1 (sl) 2017-10-10 2023-10-30 Pfizer Inc. Kristalna oblika hidrata proste baze lorlatiniba
WO2021142062A1 (en) 2020-01-10 2021-07-15 Banner Life Sciences Llc Fumarate ester dosage forms with enhanced gastrointestinal tolerability
KR102271575B1 (ko) * 2020-09-16 2021-07-01 김갑용 염의 이온교환법을 이용한 친환경 고효율 에스터화반응 기반의 에스터화합물 제조방법 및 이의 화합물
JP6865489B1 (ja) * 2020-10-20 2021-04-28 株式会社エス・ディー・エス バイオテック ２，３，５，６−テトラクロロ−１，４−ベンゼンジカルボン酸ジメチルの製造方法
CN117550970A (zh) * 2023-10-30 2024-02-13 寿光金远东变性淀粉有限公司 一种高纯度衣康酸二甲酯的生产方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1848724A (en) 1932-03-08 Alphons
US3078302A (en) 1958-09-25 1963-02-19 Monsanto Chemicals Production of dialkyl fumarates
JP2006117673A (ja) 2004-10-20 2006-05-11 Eternal Chemical Co Ltd シクロブタンテトラカルボキシレート化合物及びその製造方法

Family Cites Families (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2764609A (en) 1953-07-24 1956-09-25 Monsanto Chemicals Isomerization of dialkyl maleates to dialkyl fumarates
US3993684A (en) 1971-08-20 1976-11-23 Western Litho Plate & Supply Co. Monomeric compounds
US4239636A (en) 1978-10-23 1980-12-16 Exxon Research & Engineering Co. Thio-bis-(alkyl lactone acid esters) and thio-bis-(hydrocarbyl diacid esters) are useful additives for lubricating compositions
US4568756A (en) 1976-09-24 1986-02-04 Exxon Research & Engineering Co. Thio-bis-(alkyl lactone acid esters) and thio-bis-(hydrocarbyl diacid esters) are useful additives for lubricating compositions
US5118835A (en) 1976-09-24 1992-06-02 Exxon Research & Engineering Co. Thio-bis(alkyl lactone acid esters) and thio-bis (Hydrocarbyl diacid esters) are usefull additives for lubricating compositions
US4965375A (en) 1976-09-24 1990-10-23 Exxon Research And Engineering Co. Thio-bis-(alkyl lactone acid esters) and thio-bis-(hydrocarbyl diacid esters) are useful additives for lubricating compositions
US4417062A (en) 1976-09-24 1983-11-22 Exxon Research & Engineering Co. Thio-bis-(alkyl lactone acid esters) and thio-bis-(hydrocarbyl diacid esters) are useful additives for lubricating compositions
US4866187A (en) 1976-09-24 1989-09-12 Exxon Research & Engineering Company Thio-bis(alkyl lactone acid esters) and thio-bis-(hydrocarbyl diacid esters) are useful additives for lubricating compositions
JPS60193946U (ja) 1984-03-01 1985-12-24 内山　茂夫 変色炎を有するろうそく
JPS60193946A (ja) * 1984-03-16 1985-10-02 Nippon Oil & Fats Co Ltd ジイソプロピルフマレ−トの製造法
US5149695A (en) 1985-01-15 1992-09-22 Speiser Peter P Fumaric acid derivatives, process for the production thereof and pharmaceutical compositions containing same
CH664150A5 (de) 1985-01-15 1988-02-15 Peter Paul Prof Dr Speiser Fumarsaeureprodrug, verfahren zu seiner herstellung und dieses enthaltende darreichungsformen.
JPS61246147A (ja) 1985-04-22 1986-11-01 Nippon Shokubai Kagaku Kogyo Co Ltd マレイン酸ジアルキルエステルの精製方法
US4954277A (en) 1986-10-07 1990-09-04 Exxon Chemical Patents Inc. Lactone modified, esterified or aminated additives useful in oleaginous compositions and compositions containing same
US4963275A (en) 1986-10-07 1990-10-16 Exxon Chemical Patents Inc. Dispersant additives derived from lactone modified amido-amine adducts
US4954276A (en) 1986-10-07 1990-09-04 Exxon Chemical Patents Inc. Lactone modified adducts or reactants and oleaginous compositions containing same
US4866139A (en) 1986-10-07 1989-09-12 Exxon Chemical Patents Inc. Lactone modified, esterified dispersant additives useful in oleaginous compositions
US4906394A (en) 1986-10-07 1990-03-06 Exxon Chemical Patents Inc. Lactone modified mono-or dicarboxylic acid based adduct dispersant compositions
US5032320A (en) 1986-10-07 1991-07-16 Exxon Chemical Patents Inc. Lactone modified mono- or dicarboxylic acid based adduct dispersant compositions
US4866140A (en) 1986-10-07 1989-09-12 Exxon Chemical Patents Inc. Lactone modified adducts or reactants and oleaginous compositions containing same
DE3711155A1 (de) 1987-04-02 1988-10-13 Bayer Ag Verfahren zur herstellung von maleinsaeuredimethylester
US4820432A (en) 1987-07-24 1989-04-11 Exxon Chemical Patents Inc. Lactone-modified, Mannich base dispersant additives useful in oleaginous compositions
US4971711A (en) 1987-07-24 1990-11-20 Exxon Chemical Patents, Inc. Lactone-modified, mannich base dispersant additives useful in oleaginous compositions
US4959389A (en) 1987-10-19 1990-09-25 Speiser Peter P Pharmaceutical preparation for the treatment of psoriatic arthritis
US5424332A (en) 1987-10-19 1995-06-13 Speiser; Peter P. Pharmaceutical composition and process for the production thereof
US4943382A (en) 1988-04-06 1990-07-24 Exxon Chemical Patents Inc. Lactone modified dispersant additives useful in oleaginous compositions
US5153352A (en) 1988-10-25 1992-10-06 Bristol-Myers Squibb Company Process for preparation of intermediates of carbocyclic nucleoside analogs
ES2103536T3 (es) 1993-01-21 1997-09-16 Akzo Nobel Nv Dispersiones polimeras acuosas de secado al aire.
CN1103398A (zh) * 1993-11-30 1995-06-07 张治明 一种由顺酐生产富马酸二甲酯的工艺方法
DE19581851T1 (de) 1994-11-21 1998-02-12 Asahi Chemical Ind Härtbares Harz und dieses enthaltende Harzzusammensetzung
AU3500897A (en) 1996-06-24 1998-01-14 Cytec Technology Corp. Polymerizable urea/ureido functional monomers
US6239189B1 (en) 1997-04-01 2001-05-29 Henkel Corporation Radiation-polymerizable composition and printing inks containing same
DE19721099C2 (de) 1997-05-20 1999-12-02 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten
ATE349413T1 (de) 1997-07-11 2007-01-15 Showa Denko Kk Etherverbindungen und verfahren zu ihrer herstellung
US6376702B1 (en) 1997-07-11 2002-04-23 Showa Denko K.K. Ether compound, production thereof and curable compositions
GB9724004D0 (en) 1997-11-13 1998-10-21 Kvaerner Process Tech Ltd Process
DE19814358C2 (de) 1998-03-31 2002-01-17 Fumapharm Ag Muri Verwendung von Alkylhydrogenfumaraten zur Behandlung von Psoriasis, psoriatischer Arthritis, Neurodermitis und Enteritis regionalis Crohn
DE19839566C2 (de) 1998-08-31 2002-01-17 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten in der Transplantationsmedizin
DE19848260C2 (de) 1998-10-20 2002-01-17 Fumapharm Ag Muri Fumarsäure-Mikrotabletten
DE19853487A1 (de) 1998-11-19 2000-05-25 Fumapharm Ag Muri Verwendung von Dialkylfumaraten
US7056965B2 (en) 1999-12-27 2006-06-06 Asahi Kasei Kabushiki Kaisha Polyoxymethylene resin composition
DE10000577A1 (de) 2000-01-10 2001-07-26 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten zur Behandlung mitochondrialer Krankheiten
KR20010112941A (ko) 2000-02-15 2001-12-22 오하시 미츠오 푸마르산에스테르류의 제조방법
JP2001281800A (ja) 2000-03-31 2001-10-10 Konica Corp 熱現像写真感光材料
US6586452B1 (en) 2000-07-14 2003-07-01 Merck & Co., Inc. C1 to C4 side chain modified nodulisporic acid analogs
US20020098451A1 (en) 2000-09-07 2002-07-25 Tadashi Arimoto Photothermographic material
DE10101307A1 (de) 2001-01-12 2002-08-01 Fumapharm Ag Muri Fumarsäurederivate als NF-kappaB-Inhibitor
CA2776023A1 (en) 2001-01-12 2002-07-18 Fumapharm Ag Fumaric acid amides
JP2003160535A (ja) 2001-11-28 2003-06-03 Nof Corp 不飽和二塩基酸ジエステルの製造方法
WO2003080555A1 (en) 2002-02-28 2003-10-02 Sumitomo Chemical Company, Limited Process for producing chromone compound
DE10217314A1 (de) 2002-04-18 2003-11-13 Fumapharm Ag Muri Carbocyclische und Oxacarboncyclische Fumarsäure-Oligomere
JP2003315960A (ja) 2002-04-25 2003-11-06 Konica Minolta Holdings Inc 銀塩光熱写真ドライイメージング材料
JP4259815B2 (ja) 2002-06-06 2009-04-30 ダイセル化学工業株式会社 高純度酢酸ブチルの製造方法
DK1663197T3 (da) 2003-09-09 2008-01-07 Fumapharm Ag Anvendelse af fumarsyrederivater til behandling af hjerteinsuffiens og astma
JP4163653B2 (ja) 2004-02-27 2008-10-08 株式会社日本触媒 光学部品用硬化性組成物
US7557241B2 (en) 2004-08-30 2009-07-07 Sanyo Chemical Industries, Ltd. Method for producing α,β-unsaturated carboxylic acid ester, α,β-unsaturated carboxylic acid ester, and lubricating oil additive
SI1799196T1 (sl) 2004-10-08 2016-10-28 Forward Pharma A/S Farmacevtski sestavki z nadzorovanim sproščanjem, obsegajoči ester fumarne kisline
EP1812374A1 (en) 2004-11-10 2007-08-01 Aditech Pharma AB Novel salts of fumaric acid monoalkylesters and their pharmaceutical use
EP2096177A3 (en) 2004-12-17 2010-01-13 Metanomics GmbH Process for the production of lutein
WO2006114900A1 (en) 2005-04-22 2006-11-02 Canon Kabushiki Kaisha Magnetic toner
DE102005022845A1 (de) 2005-05-18 2006-11-23 Fumapharm Ag Thiobernsteinsäurederivate und deren Verwendung
US20080227847A1 (en) 2005-07-07 2008-09-18 Aditech Pharma Ab Novel Salts of Fumaric Acid Monoalkylesters and Their Pharmaceutical Use
JPWO2007020734A1 (ja) 2005-08-12 2009-02-19 ライオン株式会社 ナノ平滑性とエッチング耐性を有するフォトレジストポリマーならびにレジスト組成物
EP1940382A2 (en) 2005-10-07 2008-07-09 Aditech Pharma AB Combination therapy with fumaric acid esters for the treatment of autoimmune and/or inflammatory disorders
WO2007042034A1 (en) 2005-10-07 2007-04-19 Aditech Pharma Ab Controlled release pharmaceutical compositions comprising a fumaric acid ester
DE602006021637D1 (de) 2006-06-16 2011-06-09 Gumlink As Kaugummi enthaltend eine hydrophobe enzymformulierung
HUE032251T2 (en) 2007-02-08 2017-09-28 Biogen Ma Inc Neuroprotection in demyelinating diseases
EP2653873B8 (en) 2007-02-08 2022-08-24 Biogen MA Inc. Compositions and uses for treating Multiple Sclerosis
TWI525195B (zh) 2007-08-10 2016-03-11 奇諾麥提卡公司 合成烯酸及其衍生物之方法
EP2219783B1 (en) 2007-10-26 2017-10-11 Purolite International, Ltd. Controlled catalysis
EP2223950B1 (en) 2007-12-12 2018-03-07 Mitsubishi Chemical Corporation Aliphatic polyester resin and method for producing the same
EP2564839B1 (en) 2009-01-09 2016-05-11 Forward Pharma A/S Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix
EP3318249A1 (en) 2009-04-29 2018-05-09 Biogen MA Inc. Dimethyl fumarate dosage regimens for the treatment of multiple sclerosis
KR20120047251A (ko) 2009-08-07 2012-05-11 인비스타 테크놀러지스 에스.에이.알.엘. 디에스테르를 형성하기 위한 수소화 및 에스테르화
DK2533634T3 (en) 2010-02-12 2016-01-25 Biogen Ma Inc NEURO PROTECTIVE demyelinating diseases
CN102757346A (zh) 2011-04-26 2012-10-31 中国科学院兰州化学物理研究所 一种富马酸二甲酯的制备方法
MX2013013781A (es) 2011-05-26 2014-01-08 Biogen Idec Inc Metodos para tratar la esclerosis multiple y preservar y/o aumentar el contenido de mielina.
PE20141639A1 (es) 2011-06-08 2014-11-08 Biogen Idec Inc Proceso para preparar fumarato de dimetilo de alta pureza y cristalino
CN102432464A (zh) 2011-12-14 2012-05-02 费近峰 一种富马酸二甲酯的连续生产工艺
CA2862885C (en) 2012-02-07 2020-06-02 Biogen Ma Inc. Pharmaceutical compositions containing dimethyl fumarate
CN102766050A (zh) 2012-08-10 2012-11-07 太仓市运通化工厂 一种富马酸二甲酯的合成方法
AR094277A1 (es) 2012-12-21 2015-07-22 Biogen Idec Inc Derivados de fumarato sustituidos con deuterio
CN103848739A (zh) 2014-03-20 2014-06-11 徐晓宁 一种高纯度富马酸二甲酯的生产方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1848724A (en) 1932-03-08 Alphons
US3078302A (en) 1958-09-25 1963-02-19 Monsanto Chemicals Production of dialkyl fumarates
JP2006117673A (ja) 2004-10-20 2006-05-11 Eternal Chemical Co Ltd シクロブタンテトラカルボキシレート化合物及びその製造方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Ｃｈｅｍ．Ａｂｓｔｒ．，１９９８，Ｖｏｌ．１２９，Ｎｏ．３，ｐ．７７１抄録番号第１２９：２９３３６ｇ
Ｊ．Ｏｒｇ．Ｃｈｅｍ．，１９６１，Ｖｏｌ．２６，Ｎｏ．８，ｐ．２９６０－２９６３

Also Published As

Publication number Publication date
JP2014522413A (ja) 2014-09-04
HRP20180203T1 (hr) 2018-04-06
JP2016155868A (ja) 2016-09-01
PL2718257T3 (pl) 2018-04-30
MX355421B (es) 2018-04-18
US20140200363A1 (en) 2014-07-17
WO2012170923A1 (en) 2012-12-13
CY1119920T1 (el) 2018-06-27
EP2718257A4 (en) 2015-08-12
SMT201800098T1 (it) 2018-03-08
RS56972B1 (sr) 2018-05-31
HUE036085T2 (hu) 2018-06-28
US9422226B2 (en) 2016-08-23
BR112013031616A2 (pt) 2016-12-06
CO6821956A2 (es) 2013-12-31
PH12013502498A1 (en) 2014-01-20
LT2718257T (lt) 2018-03-12
EP2718257B1 (en) 2017-11-15
KR20140035995A (ko) 2014-03-24
DK2718257T3 (en) 2018-02-12
NO2820009T3 (enExample) 2018-06-30
PE20141639A1 (es) 2014-11-08
EP2718257A1 (en) 2014-04-16
SG195227A1 (en) 2013-12-30
CN103649041A (zh) 2014-03-19
EA201391638A1 (ru) 2014-05-30
AU2012267524A1 (en) 2013-12-12
IL229656A0 (en) 2014-01-30
JP6385273B2 (ja) 2018-09-05
PT2718257T (pt) 2018-02-26
SI2718257T1 (en) 2018-04-30
CA2838271A1 (en) 2012-12-13
ECSP14013123A (es) 2014-06-30
ES2659771T3 (es) 2018-03-19
MX2013014320A (es) 2014-01-31
ME02960B (me) 2018-07-20
NZ618178A (en) 2016-03-31
CL2013003483A1 (es) 2014-05-09
JP2018162266A (ja) 2018-10-18
KR20150080037A (ko) 2015-07-08

Similar Documents

Publication Publication Date Title
JP6385273B2 (ja) 高純度結晶性ジメチルフマラートの調製方法
CN101429198B (zh) 去氢骆驼蓬碱衍生物及其应用
JP6527077B2 (ja) オベチコール酸の調製、使用および固体形態
UA118034C2 (uk) Заміщений піперидилетилпіримідин як інгібітор грелін-o-ацилтрансферази
CN106458857A (zh) AHU‑377结晶型游离酸、半钙盐、α﹣苯乙胺盐及其制备方法和应用
EP4001258A1 (en) Aryl propionic acid derivative, pharmaceutical composition, and method for preparation thereof and application thereof
US12479806B2 (en) Process for preparing XPO1 inhibitors and intermediates for use in the preparation of XPO1 inhibitors
WO2024061204A1 (zh) 一种制备2-羟乙基氨基己酸酯类化合物方法及其应用
CN119462514B (zh) 依托咪酯衍生物及其制备方法和在制备麻醉药物中的用途
EP0301936A1 (fr) Dérivés de pipéridine, leur préparation et leur application en thérapeutique
JP2022507558A (ja) チエノピリドン誘導体のカリウム塩一水和物及びその調製方法
WO2025144118A1 (en) Novel polymorph of ribociclib dihydrochloride dihydrate and method of preparation
EA004862B1 (ru) Кальцийдикарбоксилатные эфиры, способы их получения, фармацевтические композиции и способ лечения
CA3246202A1 (en) CRYSTALLINE FORMS AND SALTS OF A PI3K INHIBITOR AND THEIR PROCESSES OF MANUFACTURE AND USE
JP2024508329A (ja) Ｋｉｔ－およびｐｄｇｆｒａ－媒介性疾患を治療するための化合物を製造するための合成方法および中間生成物
CN116410186B (zh) 依匹哌唑甲基脂肪酸酯及其制备方法
JPS59118746A (ja) ベンゼン誘導体
WO2023219106A1 (ja) ２－メチル－２－チアゾリンの塩
TW202535822A (zh) 氧化白藜蘆醇及其衍生物的製備方法
JP2002037761A (ja) α−ヒドロキシカルボン酸化合物の製造法
CN114605341A (zh) 一种苯并异恶唑类化合物及其制备方法
CN118557578A (zh) 一种新型铁死亡抑制剂及其在治疗铁过载相关疾病中的应用
CN113004202A (zh) 一种高纯度托伐普坦的制备方法
NO132906B (enExample)
HK40033444A (en) Crystalline 2-amino-2-(hydroxymethyl)propane-1,3-diol salt of a selective acc inhibitor

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150605

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150605

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20151026

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20151203

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20160302

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20160331

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20160502

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160603

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20160603

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20161122

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170322

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20170417

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20170616

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180308

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180605

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180807

R150 Certificate of patent or registration of utility model

Ref document number: 6385273

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees